CHF 55.50
Market Cap
CHF 3.1 Mrd.
P/E Ratio
2.3
52-Week Range
CHF 31.90 – CHF 57.00
+CHF 20.25 (+57.45%)
BB Biotech is trading at CHF 55.50, up CHF 20.25 (+57.45%) over the selected period.
What you actually receive as a Swiss investor, after the 35% withholding tax (Verrechnungssteuer).
Gross Dividend Yield
4.03%
Net Dividend Yield
2.62%
Annual Dividend / Share
CHF 2.25
Payout Ratio
9.16%
Switzerland applies a 35% withholding tax (Verrechnungssteuer) on dividends. As a Swiss tax resident, you can reclaim this amount in full through your annual tax return (DA-1 form). The net yield shown reflects what you receive before reclaiming.
Revenue Growth
116'257.7%
Profit Margins
127.3%
Earnings Growth
N/A
Return on Equity
54.8%
Explore other top Swiss companies
Market data is sourced from public financial data providers. Prices may be delayed. Data is for informational purposes only and does not constitute investment advice.